A common polymorphism in the fatty acid transport protein-1 gene associated with elevated post-prandial lipaemia and alterations in LDL particle size distribution

Atherosclerosis

Volumn 167, Issue 2, 2003, Pages 265-273

  Gertow, K ^a   Skoglund Andersson, C ^a   Eriksson, P ^a   Boquist, S ^a   Orth Gomer K ^b   Schenck Gustafsson, K ^a   Hamsten, A ^a   Fisher, R M ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b KAROLINSKA INSTITUTE   (Sweden)

Author keywords

Fatty acid transport protein; LDL particle size; Polymorphism; Post prandial lipaemia; Pyrosequencing

Indexed keywords

APOLIPOPROTEIN B100; APOLIPOPROTEIN E3; CARRIER PROTEIN; FATTY ACID; FATTY ACID TRANSPORT PROTEIN 1; LIPID; LIPOPROTEIN; LOW DENSITY LIPOPROTEIN; NUCLEAR FACTOR; TRIACYLGLYCEROL; UNCLASSIFIED DRUG; VERY LOW DENSITY LIPOPROTEIN;

ADULT; AGED; ALLELE; ARTICLE; ASSAY; COHORT ANALYSIS; CONTROLLED STUDY; DIET RESTRICTION; DISEASE ASSOCIATION; FATTY ACID BLOOD LEVEL; FEMALE; FRACTIONATION; GENETIC POLYMORPHISM; GENOTYPE; HETEROZYGOTE; HUMAN; HYPERLIPIDEMIA; INTRON; LIPID BLOOD LEVEL; LIPOPROTEIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; PARTICLE SIZE; POSTPRANDIAL STATE; PRIORITY JOURNAL; REPORTER GENE; TRIACYLGLYCEROL BLOOD LEVEL;

EID: 0038801311     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0021-9150(02)00454-9     Document Type: Article

References (32)

1. Schoonjans K., Staels B., Auwerx J. The peroxisome proliferator activated receptors (PPARS) and their effects on lipid metabolism and adipocyte differentiation. Biochim. Biophys. Acta. 1302:1996;93-109.
2. Coe N.R., Bernlohr D.A. Physiological properties and functions of intracellular fatty acid-binding proteins. Biochim. Biophys. Acta. 1391:1998;287-306.
3. Stremmel W., Strohmeyer G., Borchard F., Kochwa S., Berk P.D. Isolation and partial characterization of a fatty acid binding protein in rat liver plasma membranes. Proc. Natl. Acad. Sci. USA. 82:1985;4-8.
4. Abumrad N.A., el-Maghrabi M.R., Amri E.Z., Lopez E., Grimaldi P.A. Cloning of a rat adipocyte membrane protein implicated in binding or transport of long-chain fatty acids that is induced during preadipocyte differentiation. Homology with human CD36. J. Biol. Chem. 268:1993;17 665-17 668.
5. Schaffer J.E., Lodish H.F. Expression cloning and characterization of a novel adipocyte long chain fatty acid transport protein. Cell. 79:1994;427-436.
6. Aitman T.J., Glazier A.M., Wallace C.A., et al. Identification of Cd36 (Fat) as an insulin-resistance gene causing defective fatty acid and glucose metabolism in hypertensive rats. Nat. Genet. 21:1999;76-83.
7. Ibrahimi A., Bonen A., Blinn W.D., et al. Muscle-specific overexpression of FAT/CD36 enhances fatty acid oxidation by contracting muscle, reduces plasma triglycerides and fatty acids, and increases plasma glucose and insulin. J. Biol. Chem. 274:1999;26 761-26 766.
8. Febbraio M., Abumrad N.A., Hajjar D.P., et al. A null mutation in murine CD36 reveals an important role in fatty acid and lipoprotein metabolism. J. Biol. Chem. 274:1999;19 055-19 062.
9. Hirsch D., Stahl A., Lodish H.F. A family of fatty acid transporters conserved from mycobacterium to man. Proc. Natl. Acad. Sci. USA. 95:1998;8625-8629.
10. Martin G., Nemoto M., Gelman L., et al. The human fatty acid transport protein-1 (SLC27A1; FATP-1) cDNA and gene: organization, chromosomal localization, and expression. Genomics. 66:2000;296-304.
11. Martin G., Schoonjans K., Lefebvre A.M., Staels B., Auwerx J. Coordinate regulation of the expression of the fatty acid transport protein and acyl-CoA synthetase genes by PPARalpha and PPARgamma activators. J. Biol. Chem. 272:1997;28 210-28 217.
12. Man M.Z., Hui T.Y., Schaffer J.E., Lodish H.F., Bernlohr D.A. Regulation of the murine adipocyte fatty acid transporter gene by insulin. Mol. Endocrinol. 10:1996;1021-1028.
13. Binnert C., Koistinen H.A., Martin G., et al. Fatty acid transport protein-1 mRNA expression in skeletal muscle and in adipose tissue in humans. Am. J. Physiol. Endocrinol. Metab. 279:2000;E1072-E1079.
14. Coe N.R., Smith A.J., Frohnert B.I., Watkins P.A., Bernlohr D.A. The fatty acid transport protein (FATP1) is a very long chain acyl-CoA synthetase. J. Biol. Chem. 274:1999;36 300-36 304.
15. Nishina P.M., Johnson J.P., Naggert J.K., Krauss R.M. Linkage of atherogenic lipoprotein phenotype to the low density lipoprotein receptor locus on the short arm of chromosome 19. Proc. Natl. Acad. Sci. USA. 89:1992;708-712.
16. Arner P. Differences in lipolysis between human subcutaneous and omental adipose tissues. Ann. Med. 27:1995;435-438.
17. Stahl A., Hirsch D.J., Gimeno R.E., et al. Identification of the major intestinal fatty acid transport protein. Mol. Cell. 4:1999;299-308.
18. Boden G. Free fatty acids, insulin resistance, and type 2 diabetes mellitus. Proc. Assoc. Am. Physicians. 111:1999;241-248.
19. Meirhaeghe A., Martin G., Nemoto M., et al. Intronic polymorphism in the fatty acid transport protein 1 gene is associated with increased plasma triglyceride levels in a French population. Arterioscler. Thromb. Vasc. Biol. 20:2000;1330-1334.
20. Boquist S., Hamsten A., Karpe F., Ruotolo G. Insulin and non-esterified fatty acid relations to alimentary lipaemia and plasma concentrations of postprandial triglyceride-rich lipoproteins in healthy middle-aged men. Diabetologia. 43:2000;185-193.
21. Orth-Gomer K., Mittleman M.A., Schenck-Gustafsson K., et al. Lipoprotein(a) as a determinant of coronary heart disease in young women. Circulation. 95:1997;329-334.
22. Skoglund-Andersson C., Tang R., Bond M.G., et al. LDL particle size distribution is associated with carotid intima-media thickness in healthy 50-year-old men. Arterioscler. Thromb. Vasc. Biol. 19:1999;2422-2430.
23. Eriksson M., Egberg N., Wamala S., et al. Relationship between plasma fibrinogen and coronary heart disease in women. Arterioscler. Thromb. Vasc. Biol. 19:1999;67-72.
24. Ronaghi M., Uhlen M., Nyren P. A sequencing method based on real-time pyrophosphate. Science. 281:1998;363-365.
25. Dawson S.J., Wiman B., Hamsten A., et al. The two allele sequences of a common polymorphism in the promoter of the plasminogen activator inhibitor-1 (PAI-1) gene respond differently to interleukin-1 in HepG2 cells. J. Biol. Chem. 268:1993;10 739-10 745.
26. Alksnis M., Barkhem T., Stromstedt P.E., et al. High level expression of functional full length and truncated glucocorticoid receptor in Chinese hamster ovary cells. Demonstration of ligand-induced down-regulation of expressed receptor mRNA and protein. J. Biol. Chem. 266:1991;10 078-10 085.
27. Kalb V.F. Jr., Bernlohr R.W. A new spectrophotometric assay for protein in cell extracts. Anal. Biochem. 82:1977;362-371.
28. Packard C.J., Shepherd J. Lipoprotein heterogeneity and apolipoprotein B metabolism. Arterioscler. Thromb. Vasc. Biol. 17:1997;3542-3556.
29. Dutta-Roy A.K. Cellular uptake of long-chain fatty acids: role of membrane-associated fatty-acid-binding/transport proteins. Cell. Mol. Life Sci. 57:2000;1360-1372.
30. Peterson J., Bihain B.E., Bengtsson-Olivecrona G., et al. Fatty acid control of lipoprotein lipase: a link between energy metabolism and lipid transport. Proc. Natl. Acad. Sci. USA. 87:1990;909-913.
31. Ginsberg H.N. Synthesis and secretion of apolipoprotein B from cultured liver cells. Curr. Opin. Lipidol. 6:1995;275-280.
32. Eichner J.E., Dunn S.T., Perveen G., et al. Apolipoprotein E polymorphism and cardiovascular disease: a HuGE review. Am. J. Epidemiol. 155:2002;487-495.